The Early-Onset Juvenile Parkinsonism Gene Panel by NGS evaluates key genes linked to juvenile and early-onset forms of Parkinsonism. Using an EDTA blood sample, this test helps identify hereditary variants that influence dopamine pathways and neurodegeneration. Metropolis Healthcare uses advanced next-generation sequencing to ensure accurate detection of clinically relevant mutations. The results support early diagnosis, risk assessment, and personalized clinical management for affected individuals.
Price:
Rs. 22,680.00
Sample Type: EDTA BLOOD
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the Early-Onset Juvenile Parkinsonism Gene Panel include at Metropolis Healthcare?
It includes multiple genes associated with early-onset and juvenile Parkinsonism, analyzed through high-quality NGS technology.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare isolates DNA from EDTA blood and sequences the targeted genes using advanced next-generation sequencing platforms.
Who should consider taking this test at Metropolis Healthcare?
Individuals with early motor symptoms, a strong family history, or suspected juvenile Parkinsonism may benefit from this genetic evaluation.
What sample is required for this test at Metropolis Healthcare?
A routine EDTA blood sample is sufficient for reliable DNA extraction and sequencing.
How long does Metropolis Healthcare take to provide the results?
Turnaround time depends on sequencing and analysis steps, with reports shared promptly after thorough evaluation.
Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare offers comprehensive gene coverage, strict quality controls, and clinically focused result interpretation.
Does Metropolis Healthcare provide post-test guidance?
Yes, results are accompanied by expert insights to help clinicians understand the implications and plan further care.
Is this test suitable for children and adolescents at Metropolis Healthcare?
Yes, the panel is appropriate for pediatric and adolescent cases when juvenile Parkinsonism is suspected.